English
中文简体
中文繁体
Company
Overview
Management
SAB
Board of Directors
Partnering
Technology
Bispecific
Mix-mAb
Biologics Manufacturing
Publications
Pipeline
Overview
KN035
KN046
KN026
KN019
Investors
Information Disclosure
Corporate Governance
Stock Information
IR Contacts
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
Company
Overview
Management
SAB
Board of Directors
Partnering
Technology
Bispecific
Mix-mAb
Biologics Manufacturing
Publications
Pipeline
Overview
KN035
KN046
KN026
KN019
Investors
Information Disclosure
Corporate Governance
Stock Information
IR Contacts
News
Press Release
Media Report
Career
Corporate Culture
Job Opportunities
Contact Us
English
中文简体
中文繁体
Investors
Information Disclosure
Listing Documents
Announcements & Circulars
Corporate Governance
Stock Information
IR Contacts
Announcements & Circulars
The announcement begins in December 2019
Next Day Disclosure Return
2020-01-08
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2019
2020-01-06
FULL EXERCISE OF THE OVER-ALLOTMENT OPTION, STABILIZING ACTIONS AND END OF STABILIZATION PERIOD
2020-01-05
INSIDE INFORMATION ANNOUNCEMENT – COLLABORATIVE PARTNERSHIP AGREEMENT WITH TRACON AND 3DMED
2019-12-20
VOLUNTARY ANNOUNCEMENT - COMPLETION OF CONSTRUCTION OF THE PHASE I MANUFACTURING FACILITIES
2019-12-18
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE II CLINICAL TRIAL OF KN019 FOR RHEUMATOID ARTHRITIS TREATMENT IN CHINA
2019-12-16
Terms of Reference of the Strategy Committee
2019-12-11
Terms of Reference of the Remuneration Committee
2019-12-11
Terms of Reference of the Nomination Committee
2019-12-11
Terms of Reference of the Audit Committee
2019-12-11
Amended and Restated Memorandum of Association
2019-12-11
List of Directors and their Role and Function
2019-12-11
Announcement of Offer Price and Allotment Results
2019-12-11
Global Offering-Formal Notice
2019-12-02
